“Research use only” appears at the bottom of a great many websites, often directly beneath copy that contradicts it. It is worth being precise about what the phrase describes, because a good deal of the risk in this market comes from treating it as a spell rather than as a statement of fact.
It is a description, not a defence
RUO describes a category of product: material supplied for laboratory research, not intended for use in humans or animals, not approved by any regulator for such use, and not for diagnostic or therapeutic application. The phrase is accurate when the rest of the offering is consistent with it, and it does not become accurate merely by being written.
A regulator assessing a product does not read the disclaimer and stop. They read the whole presentation — product descriptions, marketing claims, published testimonials, blog content, social posts, customer support answers — and ask what the material is intended for. If that evidence indicates human use, the disclaimer does not neutralise it. In practice a disclaimer sitting under contradictory copy makes the position worse, because it demonstrates the seller knew the boundary and wrote past it anyway.
The framework underneath
Under the Federal Food, Drug, and Cosmetic Act, whether an article is a drug turns substantially on intended use, and intended use is established by the objective evidence of how the article is represented. That is a broader test than a label. Statements about effects, claims about outcomes, guidance on preparation or administration, and testimonials the seller chooses to publish all count as evidence.
The corollary is the part suppliers dislike: a genuinely research-use-only supplier cannot describe what its compounds do, cannot advise on preparation, handling or dosing, and cannot publish accounts of people using them. Not because those things are unhelpful, but because each one is evidence of the intended use the RUO designation says does not exist.
What it means for a purchaser
Eligibility is real. Sale is restricted to research institutions, licensed researchers, universities and laboratory R&D purchasers. A supplier who sells to anyone and mentions eligibility nowhere is not operating the restriction they claim.
Silence on certain questions is a good sign. A supplier who declines to advise on preparation is not being unhelpful; they are staying inside the category they are selling in. A supplier who answers those questions cheerfully has told you their disclaimer is decorative.
Supplier exposure becomes your problem. Enforcement interrupts supply and puts purchase records in scope. Assessing whether a supplier’s position is coherent is a supply-chain risk assessment, not fastidiousness.
How we hold the line
Everything we supply is a laboratory reference material for in-vitro research use only. We make no claim about what any compound does. We answer questions about catalogue identity, vial contents, published test results and order status, and we give no preparation, handling or dosing guidance of any kind — those determinations belong to the qualified researcher and their institution. Our catalogue is grouped by receptor system and pathway rather than by intended outcome, for the same reason.
None of that is a legal opinion, and it is not offered as one. It is a description of how we operate and why. Your institution’s own compliance office is the right authority on your obligations.
Research use only. All products supplied by Battle Born Peptides are laboratory reference materials for in-vitro research and analytical use by qualified professionals. They are not drugs, foods, dietary supplements, cosmetics or medical devices; they are not approved by the FDA or any other regulator for use in humans or animals; and they are not intended to diagnose, treat, cure, mitigate or prevent any disease, or to affect the structure or any function of the body of humans or animals. Nothing in this article is preparation, handling or dosing guidance. See our full research-use terms.